A detailed history of Laraway Financial Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Laraway Financial Advisors Inc holds 7,406 shares of NVO stock, worth $784,739. This represents 0.71% of its overall portfolio holdings.

Number of Shares
7,406
Previous 7,406 -0.0%
Holding current value
$784,739
Previous $1.06 Million 16.65%
% of portfolio
0.71%
Previous 0.9%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $5,105 - $6,795
50 Added 0.68%
7,406 $950,000
Q4 2023

Feb 07, 2024

SELL
$87.78 - $105.45 $26,334 - $31,635
-300 Reduced 3.92%
7,356 $760,000
Q3 2023

Nov 16, 2023

BUY
$90.94 - $199.54 $329,930 - $723,931
3,628 Added 90.07%
7,656 $696,000
Q2 2023

Jul 27, 2023

SELL
$155.98 - $172.65 $46,794 - $51,795
-300 Reduced 6.93%
4,028 $651,000
Q1 2023

Jun 09, 2023

BUY
$132.34 - $159.14 $572,767 - $688,757
4,328 New
4,328 $688,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Laraway Financial Advisors Inc Portfolio

Follow Laraway Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laraway Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Laraway Financial Advisors Inc with notifications on news.